Research Frontiers Incorporated REFR
0.79
0.05
6.76%
as of 25 Sep
- Market cap
- $26.2M
- P/E
- 0.0×
Follow REFR
| Older periods | Sep '25 | Dec '25 | Mar '26 | Jun '26 | |
|---|---|---|---|---|---|
P/E ratio |
+8 more quarters Free account |
0.00 | 0.00 | 0.00 | 0.00 |
P/S ratio |
43.59 | 39.31 | 45.04 | 27.72 | |
P/FCF ratio |
0.00 | 0.00 | 0.00 | 0.00 | |
P/Operating CF |
(372.82) | (94.59) | (41.36) | (94.78) | |
P/B ratio |
35.68 | 47.21 | 17.62 | 16.14 | |
Price to Tangible BV |
35.68 | 47.21 | 17.62 | 16.14 | |
EV/Sales |
42.67 | 38.72 | 43.21 | 26.06 | |
EV/EBITDA |
0.00 | 0.00 | 0.00 | 0.00 | |
EV/Operating CF |
(64.17) | (32.66) | (20.82) | (10.92) | |
EV/FCF |
(64.05) | (32.64) | (20.81) | (10.92) | |
Quick Ratio |
7.08 | 3.60 | 5.77 | 3.15 | |
Current Ratio |
7.61 | 3.84 | 6.38 | 3.54 | |
Net Debt/EBITDA |
4.40 | 0.91 | 2.63 | 1.74 | |
Debt/Assets |
0.00% | 0.00% | 0.00% | 0.00% | |
Debt/Equity |
0.00 | 0.00 | 0.00 | 0.00 | |
Asset Turnover |
0.43 | 0.36 | 0.20 | 0.23 | |
Operating CF/Net income |
0.48 | 0.61 | 1.45 | 0.29 | |
Capex/Depreciation |
(0.01) | 0.00 | 0.00 | 0.00 | |
Interest Coverage |
0.00 | 0.00 | 0.00 | 0.00 | |
Research and Development Expense of Revenue |
39.43% | 187.24% | 106.68% | 149.36% | |
Selling, General and Administrative Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Intangible Assets out of Total Assets |
0.00 | 0.00 | 0.00 | 0.00 | |
Share Based Compensation of Revenue |
0.00% | 276.98% | 0.00% | 0.00% | |
Graham Net Nets |
0.01 | 0.00 | 0.02 | 0.01 | |
Graham Number |
0.00 | 0.00 | 0.00 | 0.00 | |
Earnings Yield |
(3.48%) | (4.22%) | (7.11%) | (12.58%) | |
Free Cash Flow Yield |
(1.53%) | (3.02%) | (4.61%) | (8.61%) | |
Revenue per Share |
0.01 | 0.00 | 0.00 | 0.00 | |
Operating CF per Share |
0.00 | (0.01) | (0.02) | (0.01) | |
Capex per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Free Cash Flow per Share |
0.00 | (0.01) | (0.02) | (0.01) | |
Cash per Share |
0.03 | 0.02 | 0.04 | 0.03 | |
Shareholders Equity per Share |
0.04 | 0.03 | 0.05 | 0.03 | |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Book value per Share |
0.04 | 0.03 | 0.05 | 0.03 | |
Free Cash Flow |
(0.14) | (0.47) | (0.76) | (0.19) | |
Working Capital |
1.40 | 0.85 | 1.70 | 1.04 | |
Capital Expenditures |
0.00 | 0.00 | 0.00 | 0.00 | |
Net Current Asset Value |
0.35 | (0.17) | 0.72 | 0.10 | |
EV/EBIT |
0.00 | 0.00 | 0.00 | 0.00 | |
Capex to Sales |
0.00 | 0.00 | 0.00 | 0.00 | |
Net Profit Margin |
(83.06%) | (1,061.86%) | (385.47%) | (765.01%) | |
Price to Operating Income |
0.00 | 0.00 | 0.00 | 0.00 | |
| Other line items | |||||
Average Receivables |
0.71 | 0.53 | 0.76 | 0.37 | |
Average Payables |
0.03 | 0.11 | 0.06 | 0.08 | |
Average Assets |
2.88 | 3.15 | 3.42 | 2.82 | |
Average Common Equity |
2.16 | 1.77 | 2.11 | 1.46 |
Columns are period end dates